---
title: Immunophenotyping to Identify Peripheral Lymphocyte Subsets
description: "Case study: a validated flow cytometry method that identifies CD4 and CD8 T-cell subsets and five NK-cell subsets to support clinical studies in solid tumors."
image: https://www.crystalbiosolutions.com/hubfs/4-1.png
---

![Crystal Bio Solutions logo](https://www.crystalbiosolutions.com/hs-fs/hubfs/Crystal%20Bio%20Solutions%20logo.webp?width=330&height=150&name=Crystal%20Bio%20Solutions%20logo.webp)

- Bioanalysis & Biomarkers 
    - [All Bioanalysis & Biomarker Services](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers)
    - [PK Assays for Biologics & ADCs](https://www.crystalbiosolutions.com/services/pk-bioanalysis)
    - [NAb & ADA Immunogenicity Assays](https://www.crystalbiosolutions.com/ada-and-nab-testing-in-biologics-pk-efficacy-and-regulatory-risk)
    - [Receptor Occupancy Assays](https://www.crystalbiosolutions.com/services/receptor-occupancy-assays)
- Biologics CMC Analytical 
    - [All Biologics CMC Analytical Services](https://www.crystalbiosolutions.com/characterization-cmc-analytical)
    - [Developability Assessment](https://www.crystalbiosolutions.com/services/biologics-developability-assessment)
    - [Extended Characterization by HRMS](https://www.crystalbiosolutions.com/services/biologics-extended-characterization-hrms)
    - [Biotransformation & In Vivo CQA](https://www.crystalbiosolutions.com/services/biotransformation-in-vivo-cqa)
- [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology)
- Solutions 
    - [ADC Programs](https://www.crystalbiosolutions.com/antibody-drug-conjugates-adc)
    - [Regulatory Affairs Support](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt)
    - [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services)

- [Resources](https://www.crystalbiosolutions.com/news-and-events)
- [Case Studies](https://www.crystalbiosolutions.com/news-and-events/tag/case-study)
- [About Us](https://www.crystalbiosolutions.com/about-us)
- [Locations](https://www.crystalbiosolutions.com/locations)
- [Careers](https://www.crystalbiosolutions.com/careers-at-crystal-bio-solutions)
- [Request a Proposal](https://www.crystalbiosolutions.com/contact-us)

Sep 16, 2025

# Immunophenotyping to Identify Peripheral Lymphocyte Subsets

Case study: a validated flow cytometry method that identifies CD4 and CD8 T-cell subsets and five NK-cell subsets to support clinical studies in solid tumors.

![Immunophenotyping to Identify Peripheral Lymphocyte Subsets](https://www.crystalbiosolutions.com/hubfs/4-1.png)\\

**Summary:** Crystal Bio Solutions developed and validated a flow cytometry method that identifies CD4 and CD8 T-cell subsets and five NK-cell subsets in peripheral blood to support clinical studies in solid tumors.

## Objective

Changes in the percentage or number of lymphocytes and their subpopulations during treatment can inform pharmacodynamics, safety and efficacy. This study established a flow cytometry method to measure T- and NK-cell subsets in clinical samples from solid tumor studies.

## Challenges

Choosing cell-specific markers and selective antibodies is essential. Antibody lots from several vendors are often compared for each marker to find suitable sensitivity and specificity. Drug present in the samples can also affect assay signals, so drug interference must be assessed.

## Approach

T cells and subsets (CD4/CD8; naïve, effector, central memory and effector memory) were identified with CD4, CD8, CD45RA and CCR7. NK cells and their subpopulations were identified with CD3, CD56 and CD16.

| Parent | Subpopulation | Markers and gating |
| --- | --- | --- |
| CD4 T cells | Naïve | CD45+ CD3+ CD4+ CD45RA+ CCR7+ |
| CD4 T cells | Effector | CD45+ CD3+ CD4+ CD45RA+ CCR7− |
| CD4 T cells | Central memory (Tcm) | CD45+ CD3+ CD4+ CD45RA− CCR7+ |
| CD4 T cells | Effector memory (Tem) | CD45+ CD3+ CD4+ CD45RA− CCR7− |
| CD8 T cells | Naïve | CD45+ CD3+ CD8+ CD45RA+ CCR7+ |
| CD8 T cells | Effector | CD45+ CD3+ CD8+ CD45RA+ CCR7− |
| CD8 T cells | Central memory (Tcm) | CD45+ CD3+ CD8+ CD45RA− CCR7+ |
| CD8 T cells | Effector memory (Tem) | CD45+ CD3+ CD8+ CD45RA− CCR7− |
| NK cells | I | CD45+ CD3− CD56bright CD16− |
| NK cells | II | CD45+ CD3− CD56bright CD16dim |
| NK cells | III | CD45+ CD3− CD56dim CD16− |
| NK cells | IV | CD45+ CD3− CD56dim CD16bright |
| NK cells | V | CD45+ CD3− CD56− CD16bright |

## Results

T- and NK-cell populations were gated on their surface markers (gating diagram in the PDF). Sensitivity, precision, linearity and stability were evaluated during validation. CD4+ and CD8+ T-cell and NK-cell populations were stable for up to two weeks.

![Flow cytometry gating strategy for T and NK cells and their subsets](https://www.crystalbiosolutions.com/hs-fs/hubfs/case-studies/figures/cbs-cs5-tnk-cell-gating-strategy.webp?width=822&height=549&name=cbs-cs5-tnk-cell-gating-strategy.webp)

**Figure 1.** Gating strategy for T cells (CD4, CD8 and memory/effector subsets) and NK cell subsets.

## Conclusions

- The method identifies CD4 and CD8 T cells with their naïve, effector, central memory and effector memory subsets, and five NK-cell subsets.
- Immunophenotyping during treatment helps evaluate pharmacodynamics, safety and efficacy.
- Early alignment between clinical pharmacologists and bioanalysis/biomarker scientists on which populations to report, and how, is critical.

Related services: [Bioanalysis and biomarkers](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers) · [Receptor occupancy assays](https://www.crystalbiosolutions.com/services/receptor-occupancy-assays).

## Download the case study

Fill in the short form below and we will email you the PDF (1 page, 728 KB).

To discuss a similar study, email [cbs\_bd@crystalpharmatech.com](mailto:cbs_bd@crystalpharmatech.com) or call +1 925-558-5040.

![Crystal Bio Solutions logo (footer)](https://www.crystalbiosolutions.com/hubfs/Logo_CBS-%E7%AB%96%E7%89%88-%E5%8F%8D%E7%99%BD.png)

- [Our Services](https://www.crystalbiosolutions.com) 
    - [Bioanalysis & Biomarkers](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers)
    - [Biologics CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical)
    - [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology)
    - [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt)
    - [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services)
- [Information](https://www.crystalbiosolutions.com/news-and-events) 
    - [About Us](https://www.crystalbiosolutions.com/about-us)
    - [Quality & Compliance](https://www.crystalbiosolutions.com/quality-and-compliance)
    - [News & Events](https://www.crystalbiosolutions.com/news-and-events)
    - [Case Studies](https://www.crystalbiosolutions.com/news-and-events/tag/case-study)
    - [Scientific Articles](https://www.crystalbiosolutions.com/news-and-events/tag/blog)
    - [Careers](https://www.crystalbiosolutions.com/careers-at-crystal-bio-solutions)
- [Contact](https://www.crystalbiosolutions.com/contact-us) 
    - [Email Us](mailto:cbs_bd@crystalpharmatech.com)
    - [Contact Form](https://www.crystalbiosolutions.com/contact-us)
    - [Our Locations](https://www.crystalbiosolutions.com/locations)
    - [Crystal Group](https://www.crystalbiosolutions.com/about-us#crystal-group) 
          - [Crystal Pharmatech](https://www.crystalpharmatech.com/)
          - [Crystal NAX](https://www.crystalnax.com/)

<https://www.linkedin.com/company/crystal-bio-solutions/> [Follow us on LinkedIn News, events and openings](https://www.linkedin.com/company/crystal-bio-solutions/)

- [Privacy Policy](https://www.crystalbiosolutions.com/policies/privacy-policy)
- [Terms of Service](https://www.crystalbiosolutions.com/policies/terms-of-service)

Copyright © 2026 Crystal Bio Solutions, Inc. All rights reserved.

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Crystal Bio Solutions Scientific Team",
    "url" : "https://www.crystalbiosolutions.com/news-and-events/author/crystal-bio-solutions-scientific-team"
  },
  "dateModified" : "2026-11-21T21:20:19.090Z",
  "datePublished" : "2025-09-16T16:50:58.000Z",
  "headline" : "Immunophenotyping to Identify Peripheral Lymphocyte Subsets",
  "image" : [ "https://www.crystalbiosolutions.com/hubfs/4-1.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://www.crystalbiosolutions.com/news-and-events/immunophenotyping-to-identify-peripheral-lymphocyte-subsets",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.crystalbiosolutions.com/hubfs/Crystal%20Bio%20Solutions%20logo.webp"
    },
    "name" : "Crystal Bio Solutions"
  }
}
```